Aehr Test Systems (AEHR) P/E Ratio History
Historical price-to-earnings valuation from 1998 to 2025
Loading P/E history...
AEHR Valuation Context
How does the current P/E compare to historical and market benchmarks?
P/E Ratio Analysis
As of May 6, 2026, Aehr Test Systems (AEHR) trades at a price-to-earnings ratio of -744.1x, with a stock price of $96.73 and trailing twelve-month earnings per share of $-0.37.
The current P/E is 1175% below its 5-year average of 69.2x. Over the past five years, AEHR's P/E has ranged from a low of 1.9x to a high of 385.4x, placing the current valuation at the 0th percentile of its historical range.
Compared to the Technology sector median P/E of 27.2x, AEHR trades at a 2834% discount to its sector peers. The sector includes 357 companies with P/E ratios ranging from 0.0x to 175.4x.
Relative to the broader market, AEHR trades at a notable discount to the S&P 500 median P/E of 25.2x. Investors should consider the company's growth prospects, competitive position, and earnings quality when evaluating whether the current valuation is justified.
For a comprehensive intrinsic value estimate using discounted cash flow analysis, see our AEHR DCF Valuation Calculator →
Note: P/E ratio is just one valuation metric. It does not account for balance sheet strength, cash flow quality, or growth sustainability. Always conduct comprehensive due diligence before making investment decisions.
AEHR P/E vs Peers
P/E ratio compared to closely matched public peers
| Company | Market Cap | P/E Ratio | PEG Ratio | EPS Growth (1Y) |
|---|---|---|---|---|
| $6B | 45.0 | 2.13 | -38% | |
| $15B | 105.8 | 3.06 | -32% | |
| $12B | 216.1 | - | -22% | |
| $5B | 9999.0 | - | +100%Best | |
| $20B | 67.2 | - | +56% | |
| $7B | 83.7 | 2.39 | +50% | |
| $3B | 22.8Lowest | 0.66Best | +9% |
Peers sorted by market capitalization. P/E below peers may indicate undervaluation or lower growth expectations. Consider PEG ratio for growth-adjusted comparison.
AEHR Historical P/E Data (1998–2025)
Quarterly P/E ratios calculated from closing price and TTM EPS
| Quarter | Date | Price | TTM EPS | P/E Ratio | vs Avg |
|---|---|---|---|---|---|
| FY2025 Q3 | Fri Feb 28 2025 00:00:00 GM | $9.64 | $0.78 | 12.4x | -86% |
| FY2025 Q2 | Fri Nov 29 2024 00:00:00 GM | $11.89 | $0.75 | 15.9x | -82% |
| FY2025 Q1 | Fri Aug 30 2024 00:00:00 GM | $15.21 | $0.99 | 15.4x | -82% |
| FY2024 Q4 | Fri May 31 2024 00:00:00 GM | $11.51 | $1.12 | 10.3x | -88% |
| FY2024 Q3 | $16.27 | $0.52 | 31.4x | -64% | |
| FY2024 Q2 | $22.96 | $0.71 | 32.4x | -63% | |
| FY2024 Q1 | $51.01 | $0.63 | 80.6x | -8% | |
| FY2023 Q4 | Wed May 31 2023 00:00:00 GM | $33.02 | $0.50 | 66.6x | -24% |
| FY2023 Q3 | $33.35 | $0.49 | 67.8x | -23% | |
| FY2023 Q2 | Wed Nov 30 2022 00:00:00 GM | $26.07 | $0.43 | 60.8x | -31% |
| FY2023 Q1 | Wed Aug 31 2022 00:00:00 GM | $14.54 | $0.33 | 44.6x | -49% |
| FY2022 Q4 | $8.38 | $0.33 | 25.2x | -71% |
Average P/E for displayed period: 87.8x
See AEHR's True Return
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorIs AEHR Undervalued?
DCF intrinsic value, peer multiples, and analyst estimates — see what the stock is really worth.
View ValuationCompare AEHR vs NVDA
Side-by-side business, growth, and profitability comparison vs NVIDIA Corporation.
Start ComparisonAEHR — Frequently Asked Questions
Quick answers to the most common questions about buying AEHR stock.
Is AEHR stock overvalued or undervalued?
AEHR trades at -744.1x P/E, below its 5-year average of 69.2x. At the N/A percentile of historical range, the stock is priced at a discount to its own history.
How does AEHR's valuation compare to peers?
Aehr Test Systems P/E of -744.1x compares to sector median of 27.2x. The discount suggests lower growth expectations or higher risk.
What is AEHR's PEG ratio?
AEHR PEG ratio is N/A. Above 2.0 indicates premium valuation relative to growth rate. Historical P/E data spans 1998-2025.